References
- Miller KD , NogueiraL , DevasiaTet al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin.72(5), 409–436 (2022).
- Ciardiello F , CiardielloD , MartiniG , NapolitanoS , TaberneroJ , CervantesA. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J. Clin.72(4), 372–401 (2022).
- Dubé C , YakubuM , McCurdyBRet al. Risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: a systematic review and meta-analysis. Am. J. Gastroenterol.112(12), 1790–1801 (2017).
- Schreuders EH , RucoA , RabeneckLet al. Colorectal cancer screening: a global overview of existing programmes. Gut64(10), 1637–1649 (2015).
- Fakih MG . Metastatic colorectal cancer: current state and future directions. J. Clin. Oncol.33(16), 1809–1824 (2015).
- Poon CH , LiuY , PakSet al. Prelimbic cortical stimulation with L-methionine enhances cognition through hippocampal DNA methylation and neuroplasticity mechanisms. Aging Dis.14(1), 112–135 (2023).
- Xie H , LiuX , ZhouQet al. DNA methylation modulates aging process in adipocytes. Aging Dis.13(2), 433–446 (2022).
- Mattei AL , BaillyN , MeissnerA. DNA methylation: a historical perspective. Trends Genet.38(7), 676–707 (2022).
- Nishiyama A , NakanishiM. Navigating the DNA methylation landscape of cancer. Trends Genet.37(11), 1012–1027 (2021).
- Müller D , GyőrffyB. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim. Biophys Acta Rev. Cancer1877(3), 188722; 1–4 (2022).
- Singh MP , RaiS , PandeyA , SinghNK , SrivastavaS. Molecular subtypes of colorectal cancer: an emerging therapeutic opportunity for personalized medicine. Genes Dis.8(2), 133–145 (2021).
- Zhang X , ZhangW , CaoP. Advances in CpG island methylator phenotype colorectal cancer therapies. Front. Oncol.11, 629390 (2021).
- Shen L , WaterlandRA. Methods of DNA methylation analysis. Curr. Opin. Clin. Nutr. Metab. Care10(5), 576–581 (2007).
- Alix-Panabières C , PantelK. Liquid biopsy: from discovery to clinical application. Cancer Discov.11(4), 858–873 (2021).
- Guo S , DiepD , PlongthongkumN , FungHL , ZhangK , ZhangK. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat. Genet.49(4), 635–642 (2017).
- Issa IA , NoureddineM. Colorectal cancer screening: an updated review of the available options. World J. Gastroenterol.23(28), 5086–5096 (2017).
- Scott M , McCluggageWG , HillanKJ , HallPA , RussellSE. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int. J. Cancer118(5), 1325–1329 (2006).
- Warren JD , XiongW , BunkerAM , VaughnCP , FurtadoLV , RobertsWLet al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med.9, 133 (2011).
- Jung G , Hernández-IllánE , MoreiraL , BalaguerF , GoelA. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat. Rev. Gastroenterol. Hepatol.17(2), 111–130 (2020).
- Ebert MP , ModelF , MooneyS , HaleK , LograssoJ , Tonnes-PriddyLet al. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology131(5), 1418–1430 (2006).
- Shen Y , WangD , YuanT , FangH , ZhuC , QinJet al. Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions. Clin. Epigenetics15(1), 26 (2023).